Hematuria during endocrine therapy for prostate tumor is not necessarily due to tumor progression, and the corresponding condition may be caused by local blood vessel rupture. Endocrine therapy for prostate tumor is a kind of conservative treatment, which is mainly to control the further proliferation of tumor and kill the tumor; in the process of treatment, it may cause ischemia and necrosis of local tumor tissues, and the rupture of small blood vessels may cause hematuria, which is not necessarily the case of tumor progression. If you want to make further judgment, you can do prostate MRI for examination, through the observation of the size of the lesion and the signal change, the disease condition; once the tumor range increases, you need to consult a doctor in time for observation, under the guidance of the clinician to carry out standardized treatment, to avoid the delay of the condition.